Home > Back to Publisher > Report Information

Conducting Clinical Trials in Emerging Markets

Informa Healthcare
September 1, 2007
201 Pages - SKU: IFHC1693977

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

GCPj's report, Conducting Clinical Trials in Emerging Markets is the essential resource for strategists and global trial planners. It enables useful comparisons to be drawn on key performance indicators, such as population statistics, healthcare provision, clinical trial activity and FDA inspection findings.

It focuses on pharmaceutical clinical trials, and is laid out by region, and then by country, making it invaluable for anyone involved in global clinical research programmes.

CHAPTER 1 INTRODUCTION: 1.1 Introduction to emerging markets; 1.2 Introduction to report structure, tables and sources
CHAPTER 2 INDIA: 2.1 General information; 2.2 Clinical trials specific information; 2.3 Clinical trial activity; 2.4 Looking forward; 2.5 Summary for India
CHAPTER 3 CHINA: 3.1 General information; 3.2 Clinical trials specific information; 3.3 Clinical trial activity; 3.4 Summary for China
CHAPTER 4 SOUTH EAST ASIA: 4.1 Hong Kong; 4.2 Republic of (South) Korea; 4.3 Malaysia; 4.4 Philippines; 4.5 Singapore; 4.6 Taiwan; 4.7 Thailand; 4.8 Clinical trial activity: South East Asia; 4.9 Summary for region
CHAPTER 5 CENTRAL AND EASTERN EUROPE: 5.1 Bulgaria; 5.2 Croatia; 5.3 Czech Republic; 5.4 Estonia; 5.5 Greece; 5.6 Hungary; 5.7 Latvia; 5.8 Lithuania; 5.9 Poland; 5.10 Romania; 5.11 Russia; 5.12 Serbia; 5.13 Slovak Republic; 5.14 Slovenia; 5.15 Turkey; 5.16 Ukraine; 5.17 Clinical trial activity: CEE countries; 5.18 Summary for region
CHAPTER 6 LATIN AMERICA: 6.1 Argentina; 6.2 Brazil; 6.3 Chile; 6.4 Colombia; 6.5 Costa Rica; 6.6 Mexico; 6.7 Panama; 6.8 Peru; 6.9 Puerto Rico; 6.10 Uruguay; 6.11 Venezuela; 6.12 Clinical trials activity: Latin America; 6.13 Summary for region
CHAPTER 7 MIDDLE EAST: 7.1 Israel; 7.2 Clinical trial activity: Middle East; 7.3 Summary for region
CHAPTER 8 AFRICA: 8.1 Egypt; 8.2 South Africa; 8.3 Uganda; 8.4 Clinical trial activity: Africa; 8.5 Summary for region
CHAPTER 9 DISCUSSION AND SUMMARY
ANNEX I
REFERENCES

More Global Research & Development Reports

Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity by GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity Summary GBI Research, the leading ...

Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity by GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity Summary ...

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...

Top 700 Medical & Scientific Research (Global) by Plimsoll Publishing Ltd.
This report is an in-depth financial evaluation of the GlobalMedical & Scientific Research . Using the unique Plimsoll method of analysis, each of the top ...

Ophthalmic Drugs: World Market Prospects 2012-2022 by Visiongain
How to find trends and revenue predictions for the ophthalmic drug industry What are the commercial prospects for treating eye disorders? Visiongain's report shows you ...

See all reports like this >>

Conducting Clinical Trials in Emerging Markets

Share this report

Other tasks

Research Assistance

Related Markets

Research & Development Reports

Free Alert Me service